Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04146571
Title Expanded Access to Ensartinib for Participants With ALK+ NSCLC
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Xcovery Holding Company, LLC
Indications

lung non-small cell carcinoma

Therapies

Ensartinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST